Last 2 Days: Get Info on Potential Big Opportunity in Bluechip Stocks
Here is the latest financial fact sheet of PFIZER. For more details, see the PFIZER quarterly results and PFIZER share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 0.6 |
No. of shares | m | 45.75 |
1 Week | % | 1.6 |
1 Month | % | -0.6 |
1 Year | % | 13.4 |
52 week H/L | Rs | 4,940.0/3,725.9 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
PFIZER EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 3,840 | 4,930 | 5,875 | 6,165 | 4,662 | |
Low | Rs | 2,080 | 2,798 | 3,833 | 4,163 | 3,407 | |
Sales per share (Unadj.) | Rs | 455.0 | 470.3 | 489.3 | 570.7 | 530.0 | |
Earnings per share (Unadj.) | Rs | 93.8 | 111.3 | 108.8 | 133.9 | 136.4 | |
Diluted earnings per share | Rs | 93.8 | 111.3 | 108.8 | 133.9 | 136.4 | |
Cash flow per share (Unadj.) | Rs | 109.4 | 133.9 | 132.7 | 159.0 | 159.4 | |
Dividends per share (Unadj.) | Rs | 22.50 | 330.00 | 35.00 | 30.00 | 70.00 | |
Adj. dividends per share | Rs | 22.50 | 330.02 | 35.00 | 30.00 | 70.00 | |
Avg Dividend yield | % | 0.8 | 8.5 | 0.7 | 0.6 | 1.7 | |
Book value per share (Unadj.) | Rs | 658.2 | 742.2 | 523.1 | 626.1 | 701.0 | |
Adj. book value per share | Rs | 658.2 | 742.2 | 523.1 | 626.1 | 701.1 | |
Shares outstanding (eoy) | m | 45.75 | 45.75 | 45.75 | 45.75 | 45.75 | |
Price / Sales ratio | x | 6.5 | 8.2 | 9.9 | 9.0 | 7.6 | |
Avg P/E ratio | x | 31.6 | 34.7 | 44.6 | 38.6 | 29.6 | |
P/CF ratio (eoy) | x | 27.1 | 28.9 | 36.6 | 32.5 | 25.3 | |
Price / Book Value ratio | x | 4.5 | 5.2 | 9.3 | 8.2 | 5.8 | |
Dividend payout | % | 24.0 | 296.5 | 32.2 | 22.4 | 51.3 | |
Avg Mkt Cap | Rs m | 135,413 | 176,754 | 222,063 | 236,225 | 184,576 | |
Total wages/salary | Rs m | 3,238 | 3,645 | 3,611 | 4,037 | 3,317 |
PFIZER INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 20,815 | 21,517 | 22,386 | 26,110 | 24,248 | |
Other income | Rs m | 1,674 | 1,840 | 811 | 627 | 1,011 | |
Total revenues | Rs m | 22,489 | 23,357 | 23,197 | 26,736 | 25,258 | |
Gross profit | Rs m | 5,656 | 5,727 | 7,124 | 8,359 | 8,420 | |
Depreciation | Rs m | 714 | 1,032 | 1,094 | 1,150 | 1,055 | |
Interest | Rs m | 17 | 110 | 154 | 107 | 135 | |
Profit before tax | Rs m | 6,599 | 6,425 | 6,687 | 7,729 | 8,240 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 2,309 | 1,334 | 1,711 | 1,603 | 2,001 | |
Profit after tax | Rs m | 4,291 | 5,091 | 4,976 | 6,126 | 6,239 | |
Gross profit margin | % | 27.2 | 26.6 | 31.8 | 32.0 | 34.7 | |
Effective tax rate | % | 35.0 | 20.8 | 25.6 | 20.7 | 24.3 | |
Net profit margin | % | 20.6 | 23.7 | 22.2 | 23.5 | 25.7 |
PFIZER BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 27,017 | 30,131 | 18,733 | 23,614 | 24,933 | |
Current liabilities | Rs m | 8,917 | 8,734 | 7,743 | 8,529 | 6,574 | |
Net working cap to sales | % | 87.0 | 99.4 | 49.1 | 57.8 | 75.7 | |
Current ratio | x | 3.0 | 3.4 | 2.4 | 2.8 | 3.8 | |
Inventory Days | Days | 59 | 65 | 73 | 82 | 93 | |
Debtors Days | Days | 3 | 3 | 2 | 2 | 2 | |
Net fixed assets | Rs m | 12,246 | 13,565 | 13,440 | 14,571 | 13,780 | |
Share capital | Rs m | 458 | 458 | 458 | 458 | 458 | |
"Free" reserves | Rs m | 29,656 | 33,497 | 23,473 | 28,187 | 31,616 | |
Net worth | Rs m | 30,113 | 33,955 | 23,930 | 28,644 | 32,073 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 0 | |
Total assets | Rs m | 39,400 | 44,048 | 32,524 | 38,535 | 39,031 | |
Interest coverage | x | 384.7 | 59.4 | 44.5 | 73.2 | 62.1 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.5 | 0.5 | 0.7 | 0.7 | 0.6 | |
Return on assets | % | 10.9 | 11.8 | 15.8 | 16.2 | 16.3 | |
Return on equity | % | 14.2 | 15.0 | 20.8 | 21.4 | 19.5 | |
Return on capital | % | 22.0 | 19.2 | 28.6 | 27.4 | 26.1 | |
Exports to sales | % | 2.1 | 1.8 | 1.5 | 3.0 | 2.8 | |
Imports to sales | % | 3.8 | 1.9 | 2.3 | 2.5 | 0 | |
Exports (fob) | Rs m | 428 | 398 | 339 | 781 | 688 | |
Imports (cif) | Rs m | 786 | 411 | 510 | 652 | 8 | |
Fx inflow | Rs m | 428 | 398 | 339 | 781 | 688 | |
Fx outflow | Rs m | 786 | 411 | 510 | 652 | 8 | |
Net fx | Rs m | -358 | -14 | -171 | 130 | 679 |
PFIZER CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 978 | 3,232 | 4,273 | 6,671 | 3,557 | |
From Investments | Rs m | 351 | 15,303 | -4,688 | -5,750 | -361 | |
From Financial Activity | Rs m | -1,099 | -1,635 | -15,711 | -1,805 | -3,458 | |
Net Cashflow | Rs m | 231 | 16,900 | -16,126 | -885 | -262 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Pradip Shah | COMP SEC: Prajeet Nair | YEAR OF INC: 1950 | BSE CODE: 500680 | FV (Rs): 10 | DIV YIELD (%): 1.6 |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare PFIZER With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Stocks in Asia struggled to find direction after a slow US session, with investors divided on whether the market can maintain this month's advance.